Intrinsiqq
IO Biotech, Inc. logo

IO Biotech, Inc. Financials

IOBTQ

Compare

All currency values in $ millions unless otherwise noted

Scroll

Income Statement
DEC 2024
~1.5:1 split
DEC 2023
~1.5:1 split
DEC 2022
~6.6:1 split
DEC 2021
DEC 2020
General & Administrative$24$24$24$11$2
Research & Development$71$68$47$30$8
Total Operating Expenses$95$91$71$41$10
Operating Income-$95-$91-$71-$41-$10
Non-Operating
Net Interest Expense$5$6$1-$0-$0
Other Non-Operating Income (Expense)-$4$0$0-$26-$2
EBT (Earnings Before Tax)-$94-$85-$70-$68-$12
Income Tax Expense$1$1$1$0–
Net Income
Net Income-$95-$86-$71-$68-$12
EPS (Basic)-$1.45-$1.98-$2.48-$17.30–
EPS (Diluted)-$1.45-$1.98-$2.48-$17.30–
Weighted Avg Shares (Basic)65.9M43.5M28.8M4.3M177,200
Weighted Avg Shares (Diluted)65.9M43.5M28.8M4.3M177,200
Shares Outstanding65.9M43.5M28.8M4.3M177,200

IO Biotech (IOBTQ) financials: revenue, profit and margins

IO Biotech (IOBTQ) generated about n/a in revenue and -$88 million in net income over the trailing twelve months. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

Is IO Biotech profitable?+

IO Biotech reported about -$88 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 10 Nov 2025, covering the period ending 30 Sept 2025, as reported to the SEC. Data last refreshed 11 Sept 2026. How this is calculated.

Fiscal year ends Dec.

Peers

Pharmaceutical Preparations · Pick stocks to compare with IOBTQ

CompareIntrinsic value
LIPOLipella Pharmaceuticals Inc.
$0.00+0.00%25
CARMCarisma Therapeutics Inc.
$0.00+0.00%60
SLNOSoleno Therapeutics Inc
No recent price25
OPKOpko Health Inc.
$1.57-2.48%28
IBIOiBio, Inc.
$0.80+0.01%10
LFVNLifeVantage Corporation
$4.15-15.13%68
PAHCPhibro Animal Health Corporation
$33.29-2.32%57

Spot a number that looks wrong? Check it in IOBTQ's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing IOBTQ

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.